Jamjoom Pharma board plans 16% cash dividend for H1 2024

06/08/2024 Argaam Exclusive

The board of directors of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) recommended, on Aug. 5, a 16% cash dividend for the first half of 2024, at SAR 1.6 per share, as shown below:

 

Dividend (H1 2024)  

Current Capital 

SAR 700 mln

Number of Shares 

70 mln

Total Dividends 

SAR 112 mln

Percentage of Capital 

16% (SAR 1.6 per share)

Record Date 

Aug. 15, 2024

Payout Date 

Aug. 25, 2024

Dividend History (SAR/share) Corporate Actions

Announcement Ex-Dividend Payment Dividends
(M Riyal)
Dividends * Notes
06/08/2024 15/08/2024 25/08/2024 112.00 1.60
04/04/2024 04/06/2024 13/06/2024 105.00 1.50
10/08/2023 20/08/2023 03/09/2023 70.00 1.00
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any

Dividend History

Consolidated cash dividend Cash dividend per share (SAR) * The stock price at the beginning of the period (SAR) Return on the base price
Last 3 Financial years N/A N/A N/A
Last 5 Financial years N/A N/A N/A
Last 10 Financial years N/A N/A N/A
Based on the beginning of the period (January 1 of the base year)

Historical Dividends

ajax loading

Valuation Data (Latest Share Price)

P/E (TTM) 35.37
P/E Before Unusual Items (TTM) 35.37
P/BV 8.02
Dividend Yield 2.17 %
Market Cap. (M) 11,732.00
Return on Average Assets 19.61 %
Return on Average Equity 23.54 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.